| 000 | 01698 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517024520.0 | ||
| 264 | 0 | _c20160126 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1464-3391 | ||
| 024 | 7 |
_a10.1016/j.bmc.2015.03.064 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKieffer, Charline | |
| 245 | 0 | 0 |
_aAntileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _cMay 2015 |
||
| 300 |
_a2377-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xchemical synthesis |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeishmania donovani _xdrug effects |
| 650 | 0 | 4 |
_aLeishmania infantum _xdrug effects |
| 650 | 0 | 4 |
_aLife Cycle Stages _xdrug effects |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 |
_aNitroquinolines _xchemical synthesis |
| 650 | 0 | 4 | _aParasitic Sensitivity Tests |
| 650 | 0 | 4 |
_aPentamidine _xpharmacology |
| 650 | 0 | 4 |
_aPhosphorylcholine _xanalogs & derivatives |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aCohen, Anita | |
| 700 | 1 | _aVerhaeghe, Pierre | |
| 700 | 1 | _aPaloque, Lucie | |
| 700 | 1 | _aHutter, Sébastien | |
| 700 | 1 | _aCastera-Ducros, Caroline | |
| 700 | 1 | _aLaget, Michèle | |
| 700 | 1 | _aRault, Sylvain | |
| 700 | 1 | _aValentin, Alexis | |
| 700 | 1 | _aRathelot, Pascal | |
| 700 | 1 | _aAzas, Nadine | |
| 700 | 1 | _aVanelle, Patrice | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 23 _gno. 10 _gp. 2377-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2015.03.064 _zAvailable from publisher's website |
| 999 |
_c24777785 _d24777785 |
||